CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Equity / NAMEN AKT
Number of holders
181
Total Shares
27.4M
Shares change
+2.18M
Total reported value, excl. options
$1.29B
Value change
+$108M
Put/Call ratio
0.83
Number of buys
81
Number of sells
-62
Price
$47.10
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.